Collegium Pharmaceutical (COLL) Cash from Operations Growth (1y) (2015 - 2026)
Collegium Pharmaceutical (COLL) Cash from Operations Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 81.06% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 8.26% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -46.22% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 63.59% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 73.78% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 33.73% |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 16.88% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Collegium Pharmaceutical | 891.70 Mn | 742.38 Mn | 110.29 Mn | -1.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.54% |
| Mar 31, 2026 | 3.10% |
| Dec 31, 2025 | 45.37% |
| Sep 30, 2025 | 971.63% |
| Jun 30, 2025 | 7.48% |
| Mar 31, 2025 | -10.56% |
| Dec 31, 2024 | 15.42% |
| Sep 30, 2024 | -112.16% |
| Jun 30, 2024 | -32.41% |
| Mar 31, 2024 | 123.83% |
| Dec 31, 2023 | 10.57% |
| Sep 30, 2023 | 73.06% |
| Jun 30, 2023 | 146.53% |
| Mar 31, 2023 | 209.31% |
| Dec 31, 2022 | 83.23% |
| Sep 30, 2022 | 147.88% |
| Jun 30, 2022 | 36.96% |
| Mar 31, 2022 | -223.07% |
| Dec 31, 2021 | 60.33% |
| Sep 30, 2021 | -49.52% |